Form 4: ICU Medical CEO Vivek Jain Executes Option and Sells Shares Under 10b5-1 Plan
SEC Form 4
ICU Medical's Chairman and CEO, Vivek Jain, exercised stock options and sold shares of common stock on October 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On October 1, 2024, Vivek Jain, Chairman and CEO of ICU Medical Inc., exercised non-qualified stock options to acquire 12,000 shares of common stock at a price of $88.76 per share.
- Simultaneously, Jain sold a total of 12,000 shares of ICU Medical common stock in multiple transactions at weighted average prices ranging from $177.498 to $180.481.
- These transactions were executed under a pre-existing Rule 10b5-1 trading plan adopted on March 15, 2024.
- Following these transactions, Jain directly owns 104,593 shares and indirectly owns 88,698 shares through a trust.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports routine transactions under a pre-arranged trading plan. There's no indication of positive or negative implications for the company.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily reflect a broader industry trend. However, it's common for executives to utilize 10b5-1 plans to diversify their holdings and avoid accusations of trading on inside information.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the trades mitigates any significant concerns.
Key Dates
| Date | Description |
|---|---|
| 02/11/2018 | Date Non-Qualified Stock Option is Exercisable |
| 03/15/2024 | Date of adoption of Rule 10b5-1 trading plan |
| 10/01/2024 | Date of option exercise and stock sales |
| 02/11/2025 | Expiration Date of Non-Qualified Stock Option |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.